This content is promotional.
The mAbXmise quantification kits are intended to monitor the concentration of therapeutic monoclonal antibodies (mAbs) in samples from patients treated with these mAbs. The kit is a quantitative assay. The test can be performed on plasma (EDTA, heparin or citrate collection tubes) and serum. Assay results are intended to be used by healthcare professionals. Before use, it is important to carefully read the instructions provided with the product.
This space contains information on medical devices, the use of which is reserved for healthcare professionals. In application of the law of December 29, 2011 relating to the strengthening of health security, I certify that I am a health professional and therefore be authorized to access this information.
mAbXmise monoclonal antibodies quantification kits are In Vitro Diagnostic Medical Devices for laboratory professional use and CE-IVD labeled for Europe by BSI. Assay results are intended to be used by healthcare professionals. The kits are designed to perform absolute quantification by LC-MS (Liquid Chromatography – Mass spectrometry) of specific therapeutic monoclonal antibodies (mAbs) in a patient sample. Assay results are intended to be used by healthcare professionals. Before use, it is important to carefully read the instructions provided with the product. The products are non-refundable. The mAbXmise Kit described has not been cleared by any regulatory entity for diagnostic purposes outside of Europe. Proteomics mAbXmise Kits are not available for sale in all countries.
I am a healthcare professional
Close window if you are not a healthcare professional
We look forward to sharing our latest developments in therapeutic drug monitoring of biologics by LC-MS/MS and discussing how innovative analytical solutions can contribute to more personalized patient care.
We will present:
“LC-MS/MS Measurement of Infliximab, Adalimumab, Ustekinumab, Vedolizumab and Anti-Drug Antibodies Using mAbXmise Kits on Xevo TQ Absolute XR MS for Clinical Research.”
And throughout the congress, come and meet us at Stand #29 to discover:
• our mAbXmise kits dedicated to LC-MS/MS monitoring of therapeutic monoclonal antibodies
• our latest work on Enfortumab Vedotin and free MMAE quantification
• new technical notes demonstrating mAbXmise workflows across different LC-MS/MS platforms
From standardized sample preparation to robust quantitative workflows, our goal is to make mass spectrometry increasingly accessible for biologics monitoring and personalized therapeutic management.
